Back

The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial

8 November 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 Adjunctive Pharmacotherapy ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Associate Professor David Eccleston

University of Melbourne, Melbourne (Australia)

32 More presentations in this session

Presentation thumbnail
Clinical utility of stress echocardiography in remote indigenous and non-indigenous populations: a 10-year study in central Australia
Doctor S. Ratwatte (London, GB)
Abstract
Presentation thumbnail
Characterisation of right heart dysfunction in left ventricular systolic failure
Doctor H. Chen (Sydney, AU)
Abstract
Presentation thumbnail
The impact of coronary calcification on diagnostic performance of workstation CT derived fractional flow reserve - a multicentre experience
Ms M. Isa (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Efficacy and safety of catheter ablation combined with left atrial appendage occlusion in patients with atrial fibrillation over one year: first results in a Chinese population
Mr F. Xiao (Wenzhou, CN)
Presentation thumbnail
Novel use of CHA2DS2VASC score to select patients to undergo repeat atrial fibrillation screening
Doctor W. Sun (Shatin, HK)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

ESC Asia with APSC & AFC

8 November 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Percutaneous coronary intervention and adjunctive therapeutic strategies
thumbnail
Congress Presentation
A patient with recent non-ST elevation myocardial infarction and percutaneous coronary intervention requiring cancer surgery: what do the guidelines say?
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources